An introduction to the free radical hypothesis in Parkinson's disease

Superoxide Dismutase

McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952

Oxygen toxicity, oxygen radicals, transition metals and disease

Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330

Mitochondrial DNA and human evolution

Cann, R. L., Stoneking, M., & Wilson, A. C. (1987) · Nature · doi:10.1038/325031a0 · Cited by 3,100

Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts

Halliwell, B., & Gutteridge, J. M. C. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90305-x · Cited by 2,038

DNA damage and oxygen radical toxicity

Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974

Oxygen radicals and human disease

CROSS, C. E., HALLIWELL, B., BORISH, E. T., PRYOR, W. A., AMES, B. N., SAUL, R. L., McCORD, J. M., & HARMAN, D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-526 · Cited by 1,856

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains

Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383

An Overview of Novel Therapies for Parkinson's Disease

Fahn, S. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6382 · Cited by 7

Ropinirole in the treatment of Parkinson’s disease

Zesiewicz, T., & Hauser, R. A. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.5.697 · Cited by 7

Brain Protection

Cohadon, F. (1994) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-7091-6648-2_3 · Cited by 7

The role of lamotrigine in the treatment of epilepsy

Leppik, I. E. (1998) · Neurology · doi:10.1212/wnl.51.4.940 · Cited by 7

Iron storage and transport markers in Parkinson’s disease and MPTP-treated mice

Mash, D. C., Singer, J. T., Pablo, J. P., Basile, M. J., Bruce, J. H., & Weiner, W. J. (1993) · Key topics in brain research · doi:10.1007/978-3-7091-9322-8_9 · Cited by 6

Indicators of Oxidative Stress in Aged Fischer 344 Rats: Potential for Neurotrophic Treatment

Williams, L. R., Carter, D. B., Dunn, E., & Connor, J. R. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4757-9145-7_92 · Cited by 6

Localization of a new ferritin heavy chain sequence present in human brain mRNA to chromosome 11

Percy, M. E., Bauer, S. J., Rainey, S., McLachlan, D. R. C., Dhar, M. S., & Joshi, J. G. (1995) · Genome · doi:10.1139/g95-059 · Cited by 6

An Australian multicentre open label study of pergolide as an adjunct to levodopa in Parkinson's disease

Hely, M. A., Morris, J. G., Burns, R. J., Lander, C. M., McLaughlin, D. B., & Donnan, G. A. (1996) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(96)90056-9 · Cited by 6

Time-course evaluation of whole blood phagocytosis in mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Khan, H. A. (2004) · Inflammopharmacology · doi:10.1163/156856004773121392 · Cited by 5

Neuroprotective Strategies in Neural Grafting

Brundin, P., & Schierle, G. S. K. (2000) · Neuromethods · doi:10.1007/978-1-59259-690-4_19 · Cited by 5

Glutamyl cysteine synthetase catalytic and regulatory subunits localize to dopaminergic nigral neurons as well as to astrocytes

Yantiri, F., Gasparyan, A., & Andersen, J. K. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1066 · Cited by 5

Extracellular ATP May Induce Neuronal Degeneration by a Free‐radical Mechanisma

CHENG, Y., Chen, M., Wixom, P., & Sun, A. Y. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21834.x · Cited by 5

SYNTHESIS, CHARACTERIZATION, AND BIOLOGICAL ACTIVITY OF NOVEL N-PHENYLPROPYL-3-SUBSTITUTED INDOLINE-2-ONE DERIVATIVES

., P., Naraboli, B. S., & Biradar, J. S. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i10.21083 · Cited by 4

Oxidative Stress and Excitatory Neurotoxins in Neuropathy

Low, P. A. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50026-0 · Cited by 4

Dietary Modification of Brain Function: Effects on Neuroendocrine and Psychological Determinants of Mental Health‐ and Stress‐Related Disorders

Waladkhani, A. R., & Hellhammer, D. H. (2008) · Advances in clinical chemistry · doi:10.1016/s0065-2423(07)00005-4 · Cited by 5

Medical Treatment of Parkinson Disease

Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50009-7 · Cited by 4

Clinical trials of promising apoptosis modulating drugs

Sharma, N., Kumari, R. M., Arya, G., Gupta, N., Chandra, R., & Nimesh, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815762-6.00010-x · Cited by 4

Therapeutic strategy at the crossroad of neuroinflammation and oxidative stress in age-related neurodegenerative diseases

Shie, F., & Ling, Z. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.4.419 · Cited by 4

MPP+ and glutamate in the degeneration of nigral dopaminergic neurons

Sawada, H., & Shimohama, S. (1999) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00039-5 · Cited by 4

Management of Parkinson Disease

Murdoch, D. R., Cheer, S. M., & Wagstaff, A. J. (2004) · Disease Management & Health Outcomes · doi:10.2165/00115677-200412010-00004 · Cited by 4

Mutations in the Copper- and Zinc-Containing Superoxide Dismutase Gene are Associated with “Lou Gehrig's Disease”

(2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1993.tb03114.x · Cited by 4

New Therapeutic Approaches: Rationale and Results

Mitsumoto, H. (1995) · Springer eBooks · doi:10.1007/978-1-4471-1871-8_18 · Cited by 4

Melatonin in Parkinson’s Disease and Its Therapeutic Potential

Srinivasan, V., Srinivasan, U. S., Kaur, C., Zakaria, R., Othman, Z., Lauterbach, E. C., & Acuña-Castroviejo, D. (2013) · Springer eBooks · doi:10.1007/978-81-322-0825-9_17 · Cited by 3

Nuclear microscopy in the life sciences at the national university of singapore

Ren, M., Thong, P. S. P., Makjanić, J., Ponraj, D., & Watt, F. (1999) · Biological Trace Element Research · doi:10.1007/bf02784192 · Cited by 3

Oxidative Stress in Parkinson’s Disease

Ceballos-Picot, I. (1997) · Neuroscience intelligence unit · doi:10.1007/978-3-662-22516-5_8 · Cited by 3

The Protective Effects of Trans-Cinnamaldehyde against D-Galactose and Aluminum Chloride-Induced Cognitive Dysfunction in Mice

Ryu, J.-S., Do, J., Kang, H., & Lee, J. K. (2021) · Neurochemical Journal · doi:10.1134/s1819712421010104 · Cited by 3

Oxidative Stress with Emphasis on the Role of LAMMA in Parkinson’s Disease

Good, P. F., Perl, D. P., & Olanow, C. W. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_14 · Cited by 3

Nitric Oxide and Oxidative Damage in the CNS

Dawson, D. A. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_11 · Cited by 3

Nanoparticles for the Treatment of A lzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives

Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0122 · Cited by 3

Evidence of two mechanisms of prostaglandin release in an in vitro model of muscle damage. Possible therapeutic implications

Majumdar, R., Cwik, V. A., & Brooke, M. H. (1994) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)90088-4 · Cited by 3

Neurodegenerative Disease and Oxidative Stress: Insights from an Animal Model of Parkinsonism

Hastings, T. G., & Zigmond, M. J. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_6 · Cited by 2

Indices of Oxidative Stress in the Peripheral Blood of De Novo Patients With Parkinson’s Disease

Ilic, T. V., Jovanović, M., Jovicic, A., & Tomovic, M. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_111 · Cited by 2

Physiology and pathophysiology of basalganglia: Impact on motor system function

Weicker, H., Kinscherf, R., Diserens, K., Deigner, H., & Strüder, H. K. (2001) · European Journal of Sport Science · doi:10.1080/17461390100071209 · Cited by 2

Nuclear microscopy in Parkinson's disease

Watt, F., Lee, T., Thong, P. S. P., & Tang, S. M. (1995) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/0168-583x(95)00455-6 · Cited by 2

Dietary and Intraperitoneal Administration of Selenium Provide Comparable Protection in the 6-Hydroxydopamine Lesion Rat Model of Parkinson's Disease

Fox, C. M., Drost, M., & Mueller, S. (2007) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2

Membrane Constituencies and Receptor Subtype Contribute to Age-Related Increases in Vulnerability to Oxidative Stress

Joseph, J. A., Denisova, N., Fisher, D., Cantuti‐Castelvetri, I., & Erat, S. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_9 · Cited by 2

Advances in the Understanding of the Cause of Parkinson's Disease

Schapira, A. H. V. (1994) · Journal of the Royal Society of Medicine · doi:10.1177/014107689408700701 · Cited by 2

A soluble TNF receptor 2 agonist as a new therapeutic approach to treat autoimmune and demyelinating diseases

Fischer, R. (2011) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-1905 · Cited by 2

Evaluation of the neuroprotective effects of alpha lipoic acid-loaded folate-conjugated chitosan nanoparticles against 6-OHDA-induced apoptosis and oxidative stress in an in vitro Parkinson’s disease model

Gheybi, E., Jalili‐Nik, M., Hosseinzadeh, P., Mirzaei, S. M., Alalikhan, A., & Soukhtanloo, M. (2026) · BMC Neuroscience · doi:10.1186/s12868-025-00991-3 · Cited by 1

Nutrients and Food Constituents in Cognitive Decline and Neurodegenerative Disease

Joseph, J. A., Casadesús, G., Smith, M. A., Perry, G. L., & Shukitt‐Hale, B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391884-0.00020-2 · Cited by 1

Aging with Parkinson’s Disease

Nocera, J. R., & McGregor, K. (2018) · Handbooks in health, work, and disability · doi:10.1007/978-3-030-03916-5_8 · Cited by 1

Mitochondrial DNA as a Factor of Glaucomous Optic Neuropathy’s Development Mechanism

Газизова, И. Р., Mazunin, I., Malishevskaya, Т. N., Киселева, О. А., Gadzhiev, A. M., & Rindzhibal, A.-M. (2019) · Ophthalmology in Russia · doi:10.18008/1816-5095-2019-4-479-486 · Cited by 1

Cytotoxicity and Anti-Inflammatory Effects of Polyherbal Formulations, Joint Pain Spl and Rumalaya Forte on Lipopolysaccharide Induced Inflammation in IC-21 Macrophages

Koodalingam, A., Rajalakshmi, A., & Parthiban, E. (2021) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523019999210104203252 · Cited by 1

Therapeutical Implications of Melatonin in Alzheimer’s and Parkinson’s Diseases

Cardinali, D. P., Vigo, D. E., Olivar, N., Vidal, M. F., & Brusco, L. I. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15630-9_9 · Cited by 1

Lallemantia canescens (L) Fisch & Mey bitkisinin ve kallus doku kültürünün antioksidan aktivitesi

Başak, S. Ş., & Candan, F. (2009) · Cited by 1

Xeroderma Pigmentosum and the DNA Damage Response to Ultraviolet Light

Cleaver, J. E. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_24 · Cited by 1

Medicinal Chemistry and Brain Drug Penetrance

Hilaire, J. R., & Gendelman, H. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_49 · Cited by 1

Dopamine Oxidation and Parkinson’s Disease

Barrett, C. W., Bucher, M. L., & Hastings, T. G. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00116 · Cited by 1

Mitigation of Oxidative Stress and Inflammatory Signaling by Fruit and Walnut Polyphenols: Implications for Cognitive Aging

Joseph, J. A., Shukitt‐Hale, B., & Willis, L. (2010) · Wiley eBooks · doi:10.1002/9781444323375.ch12 · Cited by 1

Role of estrogen and iron in neurodegeneration: Open peer commentary to “Astrocytes, brain aging, and neurodegeneration” by H. Schipper

Liehr, J. G. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(06)00018-2 · Cited by 1

HYPOTHALAMIC-MEDIATED MODEL FOR CREUTZFELDT-JAKOB DISEASE: RELATION TO HEMISPHERIC CHEMICAL DOMINANCE

Kurup, R. K., & Kurup, P. A. (2003) · International Journal of Neuroscience · doi:10.1080/00207450390220312 · Cited by 1

Modulatory Role of Terminalia chebula on Erythrocyte Defenses in Young and Aged Rats

Mahesh, R., & Begum, V. H. (2007) · Journal of Pharmacology and Toxicology · doi:10.3923/jpt.2007.709.717 · Cited by 1

Carbazole Based Multifunctional Dopamine Agonists And Related Molecules As Potential Symptomatic And Disease Modifying Therapeutic Agents For Parkinson’s Disease

Elmabruk, A. S. M. (2018) · Human Biology · Cited by 1

Systematrophien

Paulus, W. (1995) · Springer eBooks · doi:10.1007/978-3-642-85179-7_13 · Cited by 1

Presymptomatic and Symptomatic Stages of Intracerebral Inclusion Body Pathology in Idiopathic Parkinson’s Disease

Braak, H., & Tredici, K. D. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_20 · Cited by 1

Beneficial Effects of Dried Berry Fruits in Human Health and Disease Prevention

Zafra‐Stone, S., Bagchi, M., & Bagchi, D. (2013) · doi:10.1002/9781118464663.ch10

Nutritional Antioxidants, Vitamins, Cognition, and Neurodegenerative Disease

Martín, A., Smith, M. A., Perry, G. L., & Joseph, J. A. (2004) · Principles of Gender-Specific Medicine · doi:10.1016/b978-012440905-7/50345-5

Chapter 3.2.2 Adenovirus vectors for gene transfer into the central nervous system

Barkats, M., Corti, O., & Mallet, J. J. (1999) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(99)80034-0

Studies on the phenotype of LXRbeta-/- mice : From malabsorption to amyotrophic lateral sclerosis

Gabbi, C. (2008)

Avaliação da expressão de genes processadores de danos oxidativos em pacientes com Alzheimer

de Oliveira, D. V. N. P. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2007.tde-17042009-152311

Caloric Restriction Versus a Diet High in Antioxidants: Are They Equipotent in Altering or Reversing the Course of Aging?

Casadesús, G., Shukitt‐Hale, B., Smith, M. A., Stellwagen, H. M., & Joseph, J. A. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1067-3_6

MICROPIXE INVESTIGATIONS: TIME SEQUENCING STUDIES IN DEGENERATIVE DISEASES

Watt, F., Ren, M., & Thong, P. S. P. (1999) · International Journal of PIXE · doi:10.1142/s0129083599000292

Beskytter røyking mot Parkinsons sykdom

Flaten, T. P. (2009) · Norsk Epidemiologi · doi:10.5324/nje.v5i2.261

Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit

Joseph, J. A., Shukitt‐Hale, B., & Casadesús, G. (2005)

Pathological Changes in Neurodegenerative Disease

Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_3

protein, and DNA in the brain of rats

Liu, J., Wang, X., Shigenaga, M. K., Yeo, H. C. H., Mori, A., & Ames, B. N. (1996)

The Beneficial Effects of Fruit and Vegetable Supplementation on Neuronal Signaling and Behavior in Aging

Joseph, J. A., Shukitt‐Hale, B., & Casadesús, G. (2006) · Humana Press eBooks · doi:10.1385/1-59259-952-4:067

Catecholamine Regulated Protein (CRP40), A Splice Variant of Mortalin-2: Functional Role in CNS Disorders

Gabriele, J. P., Groleau, S. E., Daya, R. P., Pristupa, Z. B., & Mishra, R. K. (2012) · Springer eBooks · doi:10.1007/978-94-007-3027-4_12

Studies on DNA Helicity, Stability and alpha-Synuclein-DNA Interactions in relevance to Parkinson's Disease

Muralidhar, L. H. (2005) · CFTRI Institutional Repository

Fruits, Nuts, and Brain Aging

Joseph, J. A., Shukitt‐Hale, B., & Willis, L. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch13

Ischemic Neuronal Death in the Fish Retina

Kato, S., Zhou, Z., Sugawara, K., Yasui, Y., Takizawa, N., Sugitani, K., & Mawatari, K. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5933-7_23

The Misfolding Pathway of SOD1: Implications for Drug Design in ALS

Ip, P. (2017) · TSpace (University of Toronto)

Medical treatment of Parkinson disease

Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00006-8

The 3-Acetylpyridine Model of Parkinsonism: Use of Cytochrome Oxidase Gene Expression as an Index of Alterations in Basal Ganglia Function

Deutch, A. Y., Grobin, A. C., & Dannies, P. S. (1994) · Elsevier eBooks · doi:10.1016/b978-0-08-042276-3.50032-x

Apoptosis, Glial Cells and Parkinson’s Disease

Hirsch, É. C. (2001) · Research and perspectives in neurosciences · doi:10.1007/978-3-662-04333-2_9

Etiological Considerations

Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_4

References

(1995) · Elsevier eBooks · doi:10.1016/b978-012165250-0/50023-4

P arkinson's Disease

Iacono, R. P. (2005) · Van Nostrand's Scientific Encyclopedia · doi:10.1002/0471743984.vse5375

In Memoriam – Charles Warren Olanow, MD

Kieburtz, K. D., & Vickrey, B. G. (2025) · Annals of Neurology · doi:10.1002/ana.27187

Bridging Regenerative and Restorative Stem Cell Therapies in Parkinson’s Disease

Onuigbo, C. C., Martínez-Lemus, J. D., Tharp, E., & Schiess, M. C. (2026) · Cells · doi:10.3390/cells15070578

Oxidation reactions in Parkinson's disease.

Olanow, C. W. (1990) · PubMed · Cited by 245

Dopaminergic cell death in Parkinson’s disease: a role of iron?

Javoy-Agid, F., & Faucheux, B. A. (1993) · Key topics in brain research · doi:10.1007/978-3-7091-9322-8_6

The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927

Oxidative Stress in Parkinsonʼs Disease

Olanow, C. W. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199720001-00002 · Cited by 4

Parkinsons disease and oxygen free radicals

Feng, W. (2000) · Zhongguo yaolixue tongbao · Cited by 1